NeoGenomics Inc (NEO) stock
NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3024% below fair value
$14.82−0.27 (-1.79%)
Close on Nov 20, 2026Market cap $1.92BP/E –Yield –
NeoGenomics shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
NeoGenomics's shares outstanding was 129M at Sep 30, 2026. For fiscal 2025 it was 128M, up 1.1% from the year before. Over ten years it grew 7.8% a year on average. The highest annual figure on record is 128M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 128M | +1.1% |
| FY2024 | Dec 31, 2024 | 127M | +0.9% |
| FY2023 | Dec 31, 2023 | 126M | +1.0% |
| FY2022 | Dec 31, 2022 | 124M | +3.5% |
| FY2021 | Dec 31, 2021 | 120M | +7.3% |
| FY2020 | Dec 31, 2020 | 112M | +7.9% |
| FY2019 | Dec 31, 2019 | 104M | +13.2% |
| FY2018 | Dec 31, 2018 | 92M | +15.3% |
| FY2017 | Dec 31, 2017 | 79M | +2.4% |
| FY2016 | Dec 31, 2016 | 78M | +28.1% |
| FY2015 | Dec 31, 2015 | 61M | +8.1% |
| FY2014 | Dec 31, 2014 | 56M | +6.1% |
| FY2013 | Dec 31, 2013 | 53M | +8.3% |
| FY2012 | Dec 31, 2012 | 49M | +13.9% |
| FY2011 | Dec 31, 2011 | 43M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 129M | +0.1% |
| Q2 FY2026 | Jun 30, 2026 | 131M | +2.3% |
| Q1 FY2026 | Mar 31, 2026 | 129M | +1.4% |
| Q4 FY2025 | Dec 31, 2025 | 129M | +1.2% |
| Q3 FY2025 | Sep 30, 2025 | 128M | +1.2% |
| Q2 FY2025 | Jun 30, 2025 | 128M | +1.2% |
| Q1 FY2025 | Mar 31, 2025 | 127M | +1.0% |
| Q4 FY2024 | Dec 31, 2024 | 127M | +1.0% |
| Q3 FY2024 | Sep 30, 2024 | 127M | +1.0% |
| Q2 FY2024 | Jun 30, 2024 | 126M | +0.8% |
| Q1 FY2024 | Mar 31, 2024 | 126M | +0.9% |
| Q4 FY2023 | Dec 31, 2023 | 126M | +1.0% |
| Q3 FY2023 | Sep 30, 2023 | 126M | +1.0% |
| Q2 FY2023 | Jun 30, 2023 | 125M | +1.0% |
| Q1 FY2023 | Mar 31, 2023 | 125M | +1.1% |
| Q4 FY2022 | Dec 31, 2022 | 125M | +7.7% |
| Q3 FY2022 | Sep 30, 2022 | 124M | +1.5% |
| Q2 FY2022 | Jun 30, 2022 | 124M | -5.5% |
| Q1 FY2022 | Mar 31, 2022 | 124M | +6.4% |
| Q4 FY2021 | Dec 31, 2021 | 116M | -6.9% |
| Q3 FY2021 | Sep 30, 2021 | 123M | +2.8% |
| Q2 FY2021 | Jun 30, 2021 | 131M | +21.6% |
| Q1 FY2021 | Mar 31, 2021 | 116M | +11.2% |
| Q4 FY2020 | Dec 31, 2020 | 124M | +15.3% |
| Q3 FY2020 | Sep 30, 2020 | 119M | +10.5% |
| Q2 FY2020 | Jun 30, 2020 | 108M | +5.4% |
| Q1 FY2020 | Mar 31, 2020 | 104M | +10.3% |
| Q4 FY2019 | Dec 31, 2019 | 108M | +11.3% |
| Q3 FY2019 | Sep 30, 2019 | 108M | +18.7% |
| Q2 FY2019 | Jun 30, 2019 | 102M | +13.5% |
| Q1 FY2019 | Mar 31, 2019 | 95M | +17.7% |
| Q4 FY2018 | Dec 31, 2018 | 97M | +9.3% |
| Q3 FY2018 | Sep 30, 2018 | 91M | +14.2% |
| Q2 FY2018 | Jun 30, 2018 | 90M | +13.5% |
| Q1 FY2018 | Mar 31, 2018 | 81M | +2.4% |
| Q4 FY2017 | Dec 31, 2017 | 89M | +12.9% |
| Q3 FY2017 | Sep 30, 2017 | 80M | – |
| Q2 FY2017 | Jun 30, 2017 | 79M | – |
| Q1 FY2017 | Mar 31, 2017 | 79M | – |
| Q4 FY2016 | Dec 31, 2016 | 78M | – |
See a number that looks wrong?